CHD3
protein-codingchromodomain helicase DNA binding protein 3, the group of Small nucleolar RNA protein coding host genes|PHD finger proteins|NuRD complex subunits
Gene summary
This gene encodes a member of the CHD family of proteins which are characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. This protein is one of the components of a histone deacetylase complex referred to as the Mi-2/NuRD complex which participates in the remodeling of chromatin by deacetylating histones. Chromatin remodeling is essential for many processes including transcription. Autoantibodies against this protein are found in a subset of patients with dermatomyositis. Three alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~28.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0032600
Submitter: Illumina
Inheritance Pattern: AR
Disease ID:MONDO:0032600
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0032600
Submitter: ClinGen
*CHD3* was first reported in relation to autosomal dominant Snijders Blok-Campeau syndrome in 2018 (Snijders Blok et al., PMID: 30397230). Snijders Blok-Campeau syndrome is characterized by global developmental delay, delayed speech, intellectual disability, distinctive facial features including macrocephaly, prominent forehead and hypertelorism, hypotonia, and joint laxity. The severity of neurological deficits and non-neurological features is variable. Nineteen variants, including missense, nonsense, and frameshift variants, reported in 19 probands in 4 publications (PMIDs: 30397230, 32483341, 33571694, 34535214) are included in this curation. Of note, c.2953C>T (p.Arg985Trp) is a recurrent variant reported in 6 unrelated probands (PMID: 30397230). More evidence is available in the literature, but the maximum score for genetic evidence has been reached. This gene-disease relationship is also supported by protein interaction and functional assays (PMIDs: 26867680, 31949314). In summary, there is definitive evidence supporting the relationship between *CHD3* and autosomal dominant Snijders Blok-Campeau syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on March 2 2022 (SOP version 8).
Inheritance Pattern: AD
Disease ID:MONDO:0032600
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0032600
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0032600
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Cardiovascular; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Cardiovascular
Rationale: Among other features, the condition can include congenital cardiac anomalies, and awareness may enable early identification and management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CHD3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001005273.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 6 | 65 | 8 | 80 | |
| missense | 11 | 77 | 510 | 67 | 665 | |
| nonsense | 15 | 10 | 5 | 30 | ||
| start loss | 0 | |||||
| frameshift | 14 | 11 | 7 | 32 | ||
| splice donor/acceptor (+/-2bp) | 2 | 8 | 12 | 22 | ||
| Total | 42 | 107 | 540 | 132 | 8 | 829 |
Highest pathogenic variant AF is 0.000025509404
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001005273.1 | 40 | MANE Select | |
| Ensembl | ENSP00000332628.7 | 40 | MANE Select | |
| RefSeq | NP_001005271.2 | 40 | Standard | |
| RefSeq | NP_001424433.1 | 40 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| chd3 | Danio rerio | Structure: head Quality: morphology abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
- Positive epigenetic regulation of rRNA expression
- Signal Transduction
- Epigenetic regulation of gene expression
- Gene expression (Transcription)
Biological Process
- chromatin assembly or disassembly
- regulation of transcription, DNA-templated
- regulation of transcription by RNA polymerase II
- spindle organization
- centrosome cycle
Molecular Function
- DNA binding
- RNA binding
- ATP-dependent DNA helicase activity
- helicase activity
- histone deacetylase activity
Cellular Component
- nucleus
- nucleoplasm
- nucleolus
- cytoplasm
- centrosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000380358
- Coding exons
- 40
- Length
- 27955
- Individuals with no LoFs
- 125727
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 21
- Defined
- 125748
- p
- 0.0000835
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 6.15 | 591 | 1.19e+3 | 0.498 | 0.0000735 | 13412 |
| Missense (PolyPhen) | 49 | 140.02 | 0.34996 | 1544 | ||
| Synonymous | 0.0403 | 467 | 468 | 0.998 | 0.0000295 | 3981 |
| Loss of Function | 9.10 | 10 | 115 | 0.0866 | 0.00000698 | 1267 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000065 | 0.000062 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00013 | 0.00013 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin by deacetylating histones. Required for anchoring centrosomal pericentrin in both interphase and mitosis, for spindle organization and centrosome integrity. {ECO:0000269|PubMed:17626165, ECO:0000269|PubMed:9804427}.;
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- LoFtool
- 0.0137
- RVIS EVS
- -2.48
- RVIS percentile EVS
- 0.97
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.859
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |